Kun Ke
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 14
- Pancreatic and Hepatic Oncology Research 4
- Cancer Cells and Metastasis 3
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Xiaolong Liu (12 shared papers)Jingfeng Liu (9 shared papers)Naishun Liao (7 shared papers)Yingchao Wang (10 shared papers)Bixing Zhao (10 shared papers)W. Chen (1 shared paper)Zhixiong Cai (4 shared papers)Yiping Mou (4 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Brachytherapy (2 papers)Cancer Management and Research (2 papers)Frontiers in Oncology (2 papers)Annals of Vascular Surgery (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Kun Ke
37 papers receiving 578 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 140
- Oncology 161
- Pulmonary and Respiratory Medicine 176
- Hepatology 42
- Molecular Biology 251
Countries citing papers authored by Kun Ke
This map shows the geographic impact of Kun Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Ke more than expected).
Fields of papers citing papers by Kun Ke
This network shows the impact of papers produced by Kun Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Ke. The network helps show where Kun Ke may publish in the future.
Co-authors
The 25 scholars most cited alongside Kun Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 66 | |
| 2 | 2014 | 46 | |
| 3 | 2019 | 38 | |
| 4 | 2019 | 36 | |
| 5 | 2022 | 36 | |
| 6 | 2019 | 32 | |
| 7 | 2019 | 31 | |
| 8 | 2022 | 24 | |
| 9 | 2023 | 24 | |
| 10 | 2020 | 24 | |
| 11 | 2021 | 21 | |
| 12 | 2018 | 19 | |
| 13 | 2018 | 15 | |
| 14 | 2019 | 15 | |
| 15 | 2020 | 15 | |
| 16 | 2013 | 15 | |
| 17 | 2024 | 14 | |
| 18 | 2017 | 14 | |
| 19 | 2020 | 14 | |
| 20 | 2023 | 11 |
About Kun Ke
Kun Ke is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Cancer Research and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 586 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer Mechanisms and Therapy (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), MicroRNA in disease regulation (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cancer Cells and Metastasis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Cancer Research (140 citations), Oncology (161 citations), Pulmonary and Respiratory Medicine (176 citations), Hepatology (42 citations) and Molecular Biology (251 citations). Kun Ke has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Xiaolong Liu, Jingfeng Liu, Naishun Liao, Yingchao Wang, Bixing Zhao, W. Chen, Zhixiong Cai, Yiping Mou, Xiaoyuan Zheng and Yang Weizhu. Their work appears in journals such as Frontiers in Immunology, Brachytherapy, Cancer Management and Research, Frontiers in Oncology and Annals of Vascular Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.